Sold. Biotechnology Company For Sale

This company develops patents, manufactures and sells diagnostic products to clients throughout the world and OTC, over the counter to the public. It presently has over 20 U.S .and Foreign Patents with some applicable until 2021 and more patents are pending.
This company has been selling these products since 1989 and can be located anywhere or remain in its current location (Eastern U.S. coast)
FFE, Furnishings, Fixtures and equipment is valued at $200,000 plus with an average age of 7 years.
The inventory is valued at $125,000 with an average age of 8 months.
Gross Income $525,000
Cash Flow $343,000
Revenue and Profits have increased year after year since 2007. In just a little over 3 years a new owner can reclaim his investment less the FFE and Inventory.
How many companies over the last 3 years can claim a Profit of over 65% of Revenues?

Expansion Potential
: Strong growth potential exists. First, expanding into new therapeutic areas is a large opportunity. Second, the Company can continue to expand its customer base, each a source for repeat business. Third, the Company could increase recruitment by aligning with more physicians and marketing more for patients. Fourth, the Company could simply contract for more available work. Fifth, the Company could expand to other population centers, leveraging its customer base. Sixth, the Company could expand the business it does in the growing

Market / Competition / Non-Competition Agreements
Demand for medical research significantly exceeds supply. Medical centers cannot fulfill demand. Medical practices are not focused on research. Dedicated research sites, such as the Company, are attractive to drug companies and their contract research organizations (CROs) because they are focused on research, produce high patient enrollment and quality data, and get faster results. Because of the high demand, this is a business where competition is low or non-existent.